Elagolix (Orilissa®) is the first orally-available medication in a class of medications known as gonadotropin releasing hormone (GnRH) antagonists. This medication has been approved by the United States Food and Drug Administration for the treatment of moderate to severe pelvic pain due to endometriosis. In this case report, elagolix was used to treat a […]
Subchorionic hematoma (SCH) is a blood collection that can be visualized at pelvic ultrasound and can be a source of first trimester bleeding and distress for patients. SCH has been found to be more common among pregnancies that are achieved via in vitro fertilization (IVF). The article at the link below was recently published […]
E-cigarette use, or “vaping”, due to statements of greater safety than cigarette smoking, has become more popular among adolescents and pregnant women. Moreover, it has been used more commonly in recent years as an alternative by individuals who are attempting cessation of cigarette smoking. Due to a lack of long-term and second generation data, […]
Dr. Shahryar Kavoussi discusses the association between endometriosis and potential adverse pregnancy outcomes on KVUE ABC News
Based on data from a study that was published in the journal Obstetrics & Gynecology in September 2019, an association was seen between endometriosis and an increased risk of several adverse pregnancy outcomes. Dr. Shahryar Kavoussi was interviewed by KVUE anchor Mari Salazar regarding the topic of endometriosis and such pregnancy outcomes.
Watch Dr. Kavoussi’s […]
Testing is currently available to test patients for the presence or absence of gene mutations that can be associated with genetic disorders. Genetic carrier testing specifically tests for autosomal recessive and X-linked gene mutations, which some people may have and be unaware of due to the lack of clinical manifestation in carriers who do […]
Austin specialist in female fertility, Dr. Shahryar Kavoussi is awarded the Healthgrades Honor Roll, which recognizes leading physicians in the US. What are the criteria to be recognized? Physicians must be board certified and have not received any sanctions or malpractices for a given period of time.
In addition, Dr. Kavoussi works with St. David’s […]
Dr. Shahryar Kavoussi speaks at the Infertility session at the PCS Global Obstetrics and Gynaecology Congress-2017 in Rome, Italy
Dr. Shahryar Kavoussi was invited to speak at the PCS Global Obstetrics and Gynaecology Congress-2017 in Rome, Italy. The congress took place from July 8th through July 9th, and his presentation was an update on the topic of AMH as a predictor of IVF outcomes. “The presentation that I gave at the meeting was […]
Austin based fertility specialist, Dr. Shahryar Kavoussi is honored to be recognized for his work with patients. He is again a recipient of the Patients’ Choice Award for 2016, which distinguishes physicians who have made a difference in the lives of patients. This award is based on receiving near perfect scores, as voted by […]
Dr. Shahryar Kavoussi and Dr. Thomas (Rusty) Pool co-author the chapter on Optimization of Treatment Outcomes for Assisted Reproductive Technologies in the textbook “Organization and Management of IVF Units
Dr. Shahryar Kavoussi and Dr. Thomas (Rusty) Pool have co-authored a chapter on optimization of treatment outcomes for Assisted Reproductive Technologies in the textbook “Organization and Management of IVF Units” published by Springer in 2016. “This chapter covers various clinical and laboratory techniques that are considered to optimize difficult IVF cases including topics such […]
Dr. Shahryar Kavoussi attends the Infertility session at the PCS Global Obstetrics and Gynaecology Congress 2016 in Prague, Czech Republic
Dr. Shahryar Kavoussi was invited to speak at, and serve as chair, of the PCS Global Obstetrics and Gynaecology Congress-2016 in Prague, Czech Republic. The congress took place from June 18th through June19th, and his presentation focused on AMH as a predictor of IVF outcomes. “The information that I presented at the meeting covered […]